Delivery Order SPE2DB20D3103-SPE2DB22FM3K8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,140 units of the drug meclizine 25 mg tablets. The firm-fixed-price contract has a ceiling value of $1,716.63 and a completion date of February 4, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Meclizine 25mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $5,644.91, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through a Delivery Order against an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. The IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range...
- The Defense Logistics Agency Troop Support Medical awarded a $38,390 firm fixed price delivery order to Amerisourcebergen Drug Corporation for meclizine hydrochloride. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. No subcontractors or additional context were provided regarding DLA's use of the medication. The single delivery order was issued on September 7, 2023 and concludes on...
- The Defense Logistics Agency awarded a $1,073 delivery order contract to Amerisourcebergen Drug Corporation for 1000 boxes of 25mg Meclizine tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 16-17, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics...
- This federal contract award, with ID SPE2DX15D3012|SPE2DX23F8ND6, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,003.72 Firm Fixed Price delivery order is for 4,560,618,093 units of Mefloquine HCL 250 mg Tablets and has an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,587.82, is for the delivery of 4,560,954,848 units of the drug Mefloquine HCL 250 mg tablets. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price Delivery Order. The award is not associated with any set-aside requirements. AmerisourceBergen Drug Corp holds a $999,999,999...
- This federal contract award, identified as SPE2DX15D3002|SPE2DX23F9LA1, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,556,353 units of MEFLOQUINE HCL 250 MG TABLET UD 25S, a pharmaceutical product, with a ceiling value of $1,552.39. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 12, 2023. This award is associated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,000.54 Firm Fixed Price Delivery Order is for the supply of 4560615859 - Rizatriptan 10 mg Tablet UD 18s. The contract has an ultimate completion date of April 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,002.44 firm fixed-price delivery order is for the supply of 4,564,462,943 units of Cetirizine HCl 10 mg tablets. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,803.50, is for the delivery of ondansetron odt 8 mg tablets and is designated as a firm fixed price delivery order. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM3K8Delivery Order
This federal contract award, valued at $1,094.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,988,577 units of Meclizine 25 mg tablets. This appears to be a delivery order contract with a firm fixed price pricing structure. The award has an ultimate completion date of January 20, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/19/22 |